| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/07/2014 | CN102532345B 一类o-不饱和脂肪酸酰化壳寡糖及其制备和应用 A class of o- unsaturated fatty acylated chitosan oligosaccharide and its preparation and application |
| 05/07/2014 | CN102516355B 一种苯并呋喃喹啉的肽类衍生物及其制备方法和作为抗肿瘤药物的应用 One kind of benzofuran quinoline derivative peptides and preparation method and application as anticancer drugs |
| 05/07/2014 | CN102516306B 环磷酰胺类衍生物及作为抗肿瘤药物的用途 Cyclophosphamide derivatives and use as anticancer drugs |
| 05/07/2014 | CN102516234B 色氨酸葡萄糖美拉德反应产物，及其制备方法和应用 Tryptophan glucose Maillard reaction product, its preparation method and application |
| 05/07/2014 | CN102441168B 含芹菜素及芹菜素类衍生物和Bcl-2抑制剂的药物组合物及其在制备治疗癌症的药物中的应用 Containing apigenin and apigenin derivatives and Bcl-2 inhibitors and pharmaceutical compositions for the preparation of drugs for treating cancer |
| 05/07/2014 | CN102441167B 含有芹菜素及芹菜素类衍生物和组蛋白去乙酰化酶抑制剂的药物组合物及其应用 Containing apigenin and apigenin derivatives and histone deacetylase inhibitor pharmaceutical composition and its application |
| 05/07/2014 | CN102397542B 抗血管内皮生长因子受体-1的抗体 Anti-vascular endothelial growth factor receptor-1 antibodies |
| 05/07/2014 | CN102320989B 一种紫玉盘双酰胺类衍生物及其制备方法和应用 One kind Purple disc double-lactam derivatives and their preparation method and application |
| 05/07/2014 | CN102203112B 某些化合物、组合物及方法 Some of the compounds, compositions and methods |
| 05/07/2014 | CN102199079B 一种苯酚类化合物及其制备方法和应用 One phenol compound and its preparation method and application |
| 05/07/2014 | CN102159582B 作为Edg-1受体激动剂的噁唑并嘧啶 Edg-1 receptor agonists as oxazole pyrimidine |
| 05/07/2014 | CN102146084B 3-氰基-6-氨基喹啉类衍生物、其制备方法及其在医药上的应用 3-cyano-6-amino-quinoline derivatives, their preparation and their applications in medicine |
| 05/07/2014 | CN102105162B Wnt5-α肽衍生物用于治疗黑色素瘤和胃癌的用途 Uses Wnt5-α peptide derivatives for the treatment of melanoma and gastric cancer |
| 05/07/2014 | CN102099471B 针对il-17的适配体及其用途 For il-17 and its use of aptamers |
| 05/07/2014 | CN102050877B 抗人cd20人源化抗体、其制备方法及用途 Cd20 humanized anti-human antibodies, methods for their preparation and use |
| 05/07/2014 | CN102036989B 6-杂芳基咪唑并[1,2-a]吡啶的多取代衍生物及其制备方法和治疗用途 6- heteroaryl imidazo [1,2-a] pyridine derivatives and polysubstituted preparation and therapeutic use |
| 05/07/2014 | CN102008441B Endoglin抗体偶联的脂质体及其制备方法和应用 Liposomes and its preparation method and application Endoglin antibody conjugated |
| 05/07/2014 | CN101993432B 基于咔唑的唑类查尔酮衍生物及其制备方法 Carbazole-based azole chalcone derivative and preparation method |
| 05/07/2014 | CN101977620B 用于治疗类风湿性关节炎或急性骨髓性白血病的环戊二烯并[g]喹唑啉衍生物 And [g] quinazoline derivative for the treatment of rheumatoid arthritis or acute myeloid leukemia cyclopentadiene |
| 05/07/2014 | CN101945852B 氮杂环丁烷衍生物、其制备和其在治疗中的应用 Azetidine derivatives, their preparation and their use in therapy |
| 05/07/2014 | CN101928323B 3,23,28位修饰的23-羟基白桦酸类衍生物、其制备方法、制剂及用途 3,23,28 bits modified 23-hydroxy betulinic acid derivatives, their preparation, formulation and use |
| 05/07/2014 | CN101880310B 拼合杂环的23-羟基白桦酸类衍生物、其制备方法、制剂及用途 Split heterocyclic derivative 23-hydroxy betulinic acid, and its preparation method, and use of formulations |
| 05/07/2014 | CN101856116B 一类香豆酰精脒类化合物或其植物提取物的应用 Coumaric acid spermidine a class of compounds or plant extracts application thereof |
| 05/07/2014 | CN101803492B 原核苯丙氨酸氨裂合酶的组合物及其组合物在制备治疗癌症的药物中的应用 Prokaryotic phenylalanine ammonia lyase compositions and compositions thereof in the manufacture of a medicament for the treatment of cancer |
| 05/07/2014 | CN101701032B 具有抑制基质金属蛋白酶作用的喹喔啉酮小分子类肽衍生物及其制备方法和应用 Inhibit matrix metalloproteinase role quinoxaline-ketone derivatives and their preparation and application of small molecules peptoids |
| 05/07/2014 | CN101678013B 哌啶/哌嗪衍生物 Piperidine / piperazine derivatives |
| 05/07/2014 | CN101668531B 用于治疗免疫病症的联合治疗 Combination therapy for the treatment of immune disorders |
| 05/07/2014 | CN101528731B 具有AuroraA选择性抑制作用的氨基吡啶衍生物 Selective inhibition has AuroraA aminopyridine derivative |
| 05/07/2014 | CN101516850B 适用作e1活化酶抑制剂的杂芳基化合物 Activating enzyme inhibitors suitable for e1 heteroaryl compound |
| 05/06/2014 | US8716493 Multicyclic compounds and the use thereof |
| 05/06/2014 | US8716473 Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase |
| 05/06/2014 | US8716471 Process for the preparation of tetrazine derivatives |
| 05/06/2014 | US8716455 Genetic products differentially expressed in tumors and use thereof |
| 05/06/2014 | US8716445 Compositions comprising signal peptide-containing proteins |
| 05/06/2014 | US8716346 Alkylating agent combinations in the treatment of cancer |
| 05/06/2014 | US8716323 Cyclic protein tyrosine kinase inhibitors |
| 05/06/2014 | US8716321 Methods for dosing an orally active 1,2,4-oxadiazole |
| 05/06/2014 | US8716315 Analogs of thalidomide as potential angiogenesis inhibitors |
| 05/06/2014 | US8716271 Therapeutic compositions |
| 05/06/2014 | US8716253 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 05/06/2014 | US8716246 Azuvirin peptides |
| 05/06/2014 | US8716235 Method for inhibiting metastasis by using anti-CCL3 antibodies |
| 05/06/2014 | US8716234 Cytotoxins comprising modified bouganin toxin for the treatment of cancer |
| 05/06/2014 | US8716233 NOTCH mutations leading to increased receptor signaling |
| 05/06/2014 | US8715968 Methods and reagents for modulating cholesterol levels |
| 05/06/2014 | US8715668 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof |
| 05/06/2014 | US8715341 Drug-delivery endovascular stent and method of forming the same |
| 05/06/2014 | CA2743731C Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 05/06/2014 | CA2742539C Disubstituted phthalazine hedgehog pathway antagonists |
| 05/06/2014 | CA2718271C Azetidine and cyclobutane derivatives as jak inhibitors |
| 05/06/2014 | CA2711798C Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof |
| 05/06/2014 | CA2687583C Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity |
| 05/06/2014 | CA2666371C Use of an indazolemethoxyalkanoic acid to prepare a pharmaceutical composition |
| 05/06/2014 | CA2655355C Use of rpn2 gene expression inhibitor |
| 05/06/2014 | CA2637690C Tumour vaccine comprising allogeneic or xenogeneic tumour cells |
| 05/06/2014 | CA2631292C Derivatised wt1 cancer antigen peptides and their use |
| 05/06/2014 | CA2585638C Aminopyridine derivatives having aurora a selective inhibitory action |
| 05/06/2014 | CA2577692C Methods and compositions for treatment of hematologic cancers |
| 05/06/2014 | CA2574040C Iap binding compounds |
| 05/06/2014 | CA2518262C Uses of il-23 agonists and antagonists; related reagents |
| 05/06/2014 | CA2511838C Uses of mammalian cytokine; related reagents |
| 05/06/2014 | CA2401327C Nucleic acid formulations comprising poly-amino acids for gene delivery and methods of use |
| 05/06/2014 | CA2287911C Apo-2 receptor |
| 05/01/2014 | WO2014066851A1 C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders |
| 05/01/2014 | WO2014066848A1 Super-enhancers and methods of use thereof |
| 05/01/2014 | WO2014066840A1 Aurora kinase inhibitors |
| 05/01/2014 | WO2014066795A1 Heterocyclic compounds for the inhibition of pask |
| 05/01/2014 | WO2014066700A1 Retroviral vector with mini-promoter cassette |
| 05/01/2014 | WO2014066695A1 Compositions and methods for treating estrogen-related medical disorders |
| 05/01/2014 | WO2014066692A1 Compositions and methods for treating estrogen-related medical disorders |
| 05/01/2014 | WO2014066615A1 Cancer stem cell vaccination and treatment |
| 05/01/2014 | WO2014066532A1 Combination of anti-kir and anti-ctla-4 antibodies to treat cancer |
| 05/01/2014 | WO2014066509A1 Fungal nanoparticles and methods of making and using thereof |
| 05/01/2014 | WO2014066507A1 Allogeneic autophagosome-enriched composition for the treatment of disease |
| 05/01/2014 | WO2014066498A1 Treatment of metastatic breast cancer |
| 05/01/2014 | WO2014066435A1 Etp derivatives |
| 05/01/2014 | WO2014066304A1 Compositions and methods for treating or preventing diseases or disorders associated with misregulated eif4e |
| 05/01/2014 | WO2014066243A1 Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2yl)(piperidine-3,4,4,5,5-d5)-2,6-dione} |
| 05/01/2014 | WO2014066225A1 Low toxicity topical active agent delivery system |
| 05/01/2014 | WO2014066204A1 Combination |
| 05/01/2014 | WO2014066167A1 Antibodies to interleukin-6 and uses thereof |
| 05/01/2014 | WO2014066122A1 Treatment of tumors with activated mesenchymal stem cells |
| 05/01/2014 | WO2014065751A1 Lyophilized preparations of melphalan flufenamide |
| 05/01/2014 | WO2014065572A1 Pharmaceutical composition for preventing or treating cancer, containing enoblock as active ingredient |
| 05/01/2014 | WO2014065545A1 Pharmaceutical composition containing lobarstin for preventing or treating brain cancer and combined therapy for treating brain cancer using same |
| 05/01/2014 | WO2014065513A1 Ultrasound contrast medium in which nanoparticles containing drug are combined, and preparation method therefor |
| 05/01/2014 | WO2014065440A1 Cancer cell inhibitory drug and cancer stem-cell detection probe |
| 05/01/2014 | WO2014065439A1 Cancer cell inhibitory drug and cancer stem-cell detection probe |
| 05/01/2014 | WO2014065403A1 Anti-human cd40 monoclonal antibody, and use thereof |
| 05/01/2014 | WO2014065402A1 Anti-human cd40 monoclonal antibody, and use thereof |
| 05/01/2014 | WO2014065375A1 Method for inhibiting proliferation of cell by oxidative stress |
| 05/01/2014 | WO2014065275A1 Therapeutic or prophylactic agent for tumor lysis syndrome |
| 05/01/2014 | WO2014065245A1 WEAKLY ACIDIC pH-RESPONSIVE PEPTIDE AND LIPOSOME CONTAINING SAME |
| 05/01/2014 | WO2014065012A1 E-cadherin binding agent, protein synthesis inhibitor, cancer cell growth inhibitor, and antitumoral agent |
| 05/01/2014 | WO2014064687A1 A system for delivering therapeutic agents into living cells and cells nuclei |
| 05/01/2014 | WO2014064682A1 Combinations of epidermal growth factor receptor targeting antibodies for treating cancer |
| 05/01/2014 | WO2014064654A1 Derivatives of camptothecin, a method of producing them and their use |
| 05/01/2014 | WO2014064652A2 Stable pharmaceutical composition of peginterferon alpha-2b |
| 05/01/2014 | WO2014064574A1 Functionalized hybrid magnetite-gold nanoparticles with core-shell structure |
| 05/01/2014 | WO2014064203A1 Lyve-1 antagonists for preventing or treating a pathological condition associated with lymphangiogenesis |